Golaun Odabaei is a Nephrology physician affiliated with University of California, Davis. OpenAlex indexes 6 publications with 239 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2905 Telegraph Ave
Berkeley, CA 947052017
Telephone
510-841-4525Registry record last updated 13 Feb 2016.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20241 payment
- Novartis Pharmaceuticals CorporationProgram year20231 payment
- Amgen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.9%Calcium channel blocker14.9%Amlodipine Besylate52%Nifedipine Er48%Part D<11 patientsLoop diuretic8.5%Furosemide100%Part D≥13 patients+ 4 more classes in this area
Other
21.8%Phosphate Binder21.8%Sevelamer Carbonate100%Part D≥19 patientsMetabolism & gastrointestinal
15.9%Potassium supplement11.4%Potassium Chloride100%Part D<11 patientsOsmotic Laxative4.5%Lactulose100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safe botulinum toxin type A injection in patients with history of eyelid ptosis
Journal of Cosmetic Dermatology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Ezra Amsterdam, MD
University of California, Davis
Michael Rogawski, MD
University of California, Davis
Christopher Bowlus, MD
University of California, Davis
Emanual Maverakis, MD
University of California, Davis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”